Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fianium is a leading developer and manufacturer of ultrafast fiber lasers, specializing in supercontinuum (white light) laser sources. These high-performance laser systems are essential tools in the life sciences, particularly for advanced microscopy techniques such as STED (Stimulated Emission Depletion) and FLIM (Fluorescence-Lifetime Imaging Microscopy). The company's technology enables researchers to perform high-resolution imaging and complex spectroscopic analysis with greater precision. In 2016, Fianium was acquired by NKT Photonics, integrating its portfolio into a broader range of industrial and scientific laser solutions. The acquisition combined Fianium's expertise in ultrafast lasers with NKT's global reach and manufacturing scale. Today, the legacy of Fianium's innovation continues to drive advancements in bio-imaging and diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fianium.